Gene therapy (introducing genetic material into living cells to fix, replace, enhance, or block a faulty gene) is rapidly ...

The Southeast Asia molecular diagnostics market is set to grow from USD 528.3 million in 2024 to USD 891.9 million by 2031, at a 7.8% CAGR. Key drivers include a rising elderly population, increased ...

Mass photometry enables rapid, purification-free quantification of rAAV vectors, offering a faster solution for gene therapy manufacturing.

Overall survival (OS) in BRCA -mutated breast cancer improved significantly with the addition of olaparib (Lynparza) to ...

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its cell and gene therapy (CGT) portfolio with an enhanced digital PCR (dPCR) workflow that now includes solutions ...

NewBiologix, a next-generation biotechnology company pioneering the future of recombinant adeno-associated virus (rAAV) production through a unique DNA-based platform built on stable cell line ...

PCR is a strong laboratory technique that amplifies nucleic acid materials for molecular biology applications like sequencing and gene expression profiling. PCR purification, also known as PCR ...

It builds up a particularly high amount of biomass and thrives in harsh conditions. Certain varieties even produce more sugar ...

FMS-like tyrosine kinase 3 (FLT3) mutations represent some of the most pivotal genetic alterations in acute myeloid leukemia (AML), influencing ...

A multi-institutional collaboration of synthetic biology research centers in China has developed a genetically engineered ...